Prometheus Laboratories
After Spin Off From Prometheus, ProciseDx Targets POC Tests for Inflammatory, Autoimmune Conditions
Premium
The firm is conducting clinical trials in preparation for applying for FDA clearance to market its POC instrument and first assay in the first quarter of next year.
Nestlé Health Science Sells Prometheus Laboratories, Layoffs Anticipated
Nestlé Health said that employees of Prometheus are becoming employees of Precision IBD, with the exception of those working in its point-of-care diagnostic business.
PredictImmune's test relies on a 16-marker panel run using quantitative PCR to stratify Crohn's disease and ulcerative colitis patients according to the severity of their illnesses.
Palmetto Releases Draft Coverage Determinations for Several Molecular Diagnostics
The Medicare contractor proposed coverage for several cancer assays, but would not cover molecular respiratory virus assays or a test for inflammatory bowel disease.